Bell Rock Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$423K Buy
+1,309
New +$415K 0.52% 47
2022
Q2
Sell
-1,584
Closed -$488K 82
2022
Q1
$488K Buy
1,584
+6
+0.4% +$1.54K 0.46% 56
2021
Q4
$421K Buy
+1,578
New +$400K 0.31% 66
2020
Q3
$271K Buy
1,833
+7
+0.4% +$1.08K 0.33% 64
2020
Q2
$300K Buy
1,826
+7
+0.4% +$1.07K 0.39% 52
2020
Q1
$252K Buy
1,819
+7
+0.4% +$962 0.39% 53
2019
Q4
$238K Buy
1,812
+8
+0.4% +$927 0.2% 92
2019
Q3
$201K Sell
1,804
-93
-5% -$10.4K 0.18% 100
2019
Q2
$210K Buy
1,897
+505
+36% +$59.5K 0.18% 97
2019
Q1
$180K Buy
1,392
+591
+74% +$71.9K 0.1% 133
2018
Q4
$93K Buy
801
+1
+0.1% +$112 0.06% 182
2018
Q3
$86K Hold
800
0.04% 208
2018
Q2
$68K Hold
800
0.03% 227
2018
Q1
$62K Buy
+800
New +$64.4K 0.03% 234

Other funds holding LLY

Bell Rock Capital's LLY Position: Q3 2022 in Review

Bell Rock Capital opened a new position in Eli Lilly (LLY) in Q3 2022: 1,309 shares worth $423K. The stake represents 0.52% of the portfolio and ranks #47 among its holdings. This is a return to the name: Bell Rock Capital previously reported a position in LLY as recently as Q1 2022.

Bell Rock Capital first reported a position in LLY in Q1 2018 and has held it in 14 quarters since. The position peaked at $488K in Q1 2022. 2,484 funds tracked by Wall St. Rank hold LLY as of Q3 2022.

  • Bell Rock Capital held 1,309 shares of Eli Lilly worth $423K as of Q3 2022.
  • Eli Lilly was a new Bell Rock Capital position in Q3 2022.
  • Eli Lilly made up 0.52% of Bell Rock Capital's portfolio in Q3 2022, its #47 holding.
  • Bell Rock Capital first reported a position in Eli Lilly in Q1 2018 and has held it in 14 quarters since.
  • Bell Rock Capital's Eli Lilly position peaked at $488K in Q1 2022.
  • 2,484 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2022.

Based on Bell Rock Capital's 13F filing for Q3 2022, filed 28 Oct 2022.